Dr Reddys Laboratories Stock Current Asset

RDY Stock  USD 72.31  0.49  0.67%   
Dr Reddys Laboratories fundamentals help investors to digest information that contributes to Dr Reddys' financial success or failures. It also enables traders to predict the movement of RDY Stock. The fundamental analysis module provides a way to measure Dr Reddys' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Dr Reddys stock.
Non Current Assets Total is likely to drop to about 95.9 B in 2024. Other Current Assets is likely to drop to about 9.8 B in 2024.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

RDY Current Asset Analysis

Dr Reddys' Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
 2021 2022 2023 2024 (projected)
Other Current Liabilities41.6B48.9B56.2B59.0B
Total Assets296.7B322.9B371.3B206.1B

Current Asset

 = 

Cash

+

Deposits

+

Liquid Assets

More About Current Asset | All Equity Analysis

Current Dr Reddys Current Asset

    
  1.81 B  
Most of Dr Reddys' fundamental indicators, such as Current Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Dr Reddys Laboratories is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

RDY Current Asset Driver Correlations

Understanding the fundamental principles of building solid financial models for Dr Reddys is extremely important. It helps to project a fair market value of RDY Stock properly, considering its historical fundamentals such as Current Asset. Since Dr Reddys' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Dr Reddys' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Dr Reddys' interrelated accounts and indicators.
0.970.96-0.071.0-0.14-0.130.920.990.910.98-0.16-0.2-0.050.961.00.990.990.331.00.040.960.03-0.070.19-0.14-0.180.10.030.020.01
0.971.00.090.97-0.04-0.20.970.960.880.95-0.04-0.160.040.910.970.980.960.320.98-0.090.920.11-0.020.12-0.2-0.140.140.140.120.16
0.961.00.160.96-0.01-0.180.970.930.880.920.02-0.120.10.880.960.970.950.30.96-0.150.90.150.040.07-0.18-0.110.130.20.180.2
-0.070.090.16-0.090.7-0.010.17-0.180.03-0.220.880.540.82-0.28-0.08-0.09-0.1-0.16-0.06-0.85-0.260.690.71-0.550.040.4-0.130.810.820.67
1.00.970.96-0.09-0.16-0.130.910.990.90.98-0.18-0.23-0.060.960.990.990.990.320.990.030.960.03-0.060.24-0.14-0.20.10.030.010.0
-0.14-0.04-0.010.7-0.160.08-0.13-0.230.01-0.270.80.640.86-0.28-0.14-0.19-0.17-0.43-0.15-0.75-0.270.710.73-0.340.120.58-0.620.430.490.22
-0.13-0.2-0.18-0.01-0.130.08-0.28-0.120.19-0.150.310.550.01-0.04-0.17-0.16-0.08-0.27-0.170.19-0.14-0.070.14-0.171.00.42-0.52-0.26-0.23-0.25
0.920.970.970.170.91-0.13-0.280.890.770.89-0.03-0.210.030.810.920.930.90.410.93-0.120.850.11-0.08-0.01-0.27-0.140.310.250.230.3
0.990.960.93-0.180.99-0.23-0.120.890.891.0-0.26-0.26-0.170.980.990.990.980.360.980.160.99-0.1-0.170.27-0.14-0.230.13-0.1-0.12-0.06
0.910.880.880.030.90.010.190.770.890.870.070.140.020.90.890.890.910.130.880.030.870.060.140.170.19-0.02-0.09-0.02-0.01-0.02
0.980.950.92-0.220.98-0.27-0.150.891.00.87-0.31-0.3-0.210.980.980.990.980.380.980.190.99-0.13-0.230.29-0.17-0.250.16-0.13-0.15-0.07
-0.16-0.040.020.88-0.180.80.31-0.03-0.260.07-0.310.850.72-0.32-0.19-0.2-0.18-0.35-0.18-0.7-0.320.70.76-0.490.360.68-0.30.60.640.48
-0.2-0.16-0.120.54-0.230.640.55-0.21-0.260.14-0.30.850.4-0.26-0.23-0.24-0.23-0.34-0.24-0.26-0.270.380.59-0.340.60.75-0.330.180.210.16
-0.050.040.10.82-0.060.860.010.03-0.170.02-0.210.720.4-0.24-0.06-0.11-0.07-0.37-0.04-0.9-0.240.690.76-0.450.040.34-0.530.640.70.3
0.960.910.88-0.280.96-0.28-0.040.810.980.90.98-0.32-0.26-0.240.950.960.970.240.940.240.98-0.16-0.190.38-0.06-0.290.07-0.2-0.22-0.14
1.00.970.96-0.080.99-0.14-0.170.920.990.890.98-0.19-0.23-0.060.950.990.980.351.00.050.960.02-0.10.19-0.18-0.190.120.020.010.0
0.990.980.97-0.090.99-0.19-0.160.930.990.890.99-0.2-0.24-0.110.960.990.990.350.990.080.97-0.03-0.130.22-0.17-0.210.16-0.02-0.040.03
0.990.960.95-0.10.99-0.17-0.080.90.980.910.98-0.18-0.23-0.070.970.980.990.240.980.040.960.02-0.070.24-0.09-0.220.070.01-0.010.0
0.330.320.3-0.160.32-0.43-0.270.410.360.130.38-0.35-0.34-0.370.240.350.350.240.350.30.37-0.34-0.47-0.16-0.29-0.010.51-0.11-0.20.02
1.00.980.96-0.060.99-0.15-0.170.930.980.880.98-0.18-0.24-0.040.941.00.990.980.350.020.950.05-0.080.18-0.18-0.190.130.060.050.03
0.04-0.09-0.15-0.850.03-0.750.19-0.120.160.030.19-0.7-0.26-0.90.240.050.080.040.30.020.24-0.82-0.770.350.15-0.250.3-0.82-0.84-0.47
0.960.920.9-0.260.96-0.27-0.140.850.990.870.99-0.32-0.27-0.240.980.960.970.960.370.950.24-0.19-0.220.33-0.16-0.250.15-0.2-0.23-0.12
0.030.110.150.690.030.71-0.070.11-0.10.06-0.130.70.380.69-0.160.02-0.030.02-0.340.05-0.82-0.190.7-0.17-0.030.42-0.260.780.820.45
-0.07-0.020.040.71-0.060.730.14-0.08-0.170.14-0.230.760.590.76-0.19-0.1-0.13-0.07-0.47-0.08-0.77-0.220.7-0.080.170.26-0.390.640.640.32
0.190.120.07-0.550.24-0.34-0.17-0.010.270.170.29-0.49-0.34-0.450.380.190.220.24-0.160.180.350.33-0.17-0.08-0.21-0.570.08-0.35-0.4-0.29
-0.14-0.2-0.180.04-0.140.121.0-0.27-0.140.19-0.170.360.60.04-0.06-0.18-0.17-0.09-0.29-0.180.15-0.16-0.030.17-0.210.46-0.52-0.22-0.19-0.21
-0.18-0.14-0.110.4-0.20.580.42-0.14-0.23-0.02-0.250.680.750.34-0.29-0.19-0.21-0.22-0.01-0.19-0.25-0.250.420.26-0.570.46-0.270.130.150.04
0.10.140.13-0.130.1-0.62-0.520.310.13-0.090.16-0.3-0.33-0.530.070.120.160.070.510.130.30.15-0.26-0.390.08-0.52-0.270.130.040.28
0.030.140.20.810.030.43-0.260.25-0.1-0.02-0.130.60.180.64-0.20.02-0.020.01-0.110.06-0.82-0.20.780.64-0.35-0.220.130.130.970.76
0.020.120.180.820.010.49-0.230.23-0.12-0.01-0.150.640.210.7-0.220.01-0.04-0.01-0.20.05-0.84-0.230.820.64-0.4-0.190.150.040.970.68
0.010.160.20.670.00.22-0.250.3-0.06-0.02-0.070.480.160.3-0.140.00.030.00.020.03-0.47-0.120.450.32-0.29-0.210.040.280.760.68
Click cells to compare fundamentals
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
Competition

RDY Total Assets

Total Assets

206.07 Billion

At this time, Dr Reddys' Total Assets are fairly stable compared to the past year.
In accordance with the recently published financial statements, Dr Reddys Laboratories has a Current Asset of 1.81 B. This is 16.03% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The current asset for all United States stocks is 80.65% higher than that of the company.

RDY Current Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Dr Reddys' direct or indirect competition against its Current Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Dr Reddys could also be used in its relative valuation, which is a method of valuing Dr Reddys by comparing valuation metrics of similar companies.
Dr Reddys is currently under evaluation in current asset category among related companies.

RDY Fundamentals

About Dr Reddys Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Dr Reddys Laboratories's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dr Reddys using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dr Reddys Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2024
Non Current Assets Total136.4 B95.9 B
Other Current Assets17.4 B9.8 B
Total Current Assets234.9 B120.7 B
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Dr Reddys in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Dr Reddys' short interest history, or implied volatility extrapolated from Dr Reddys options trading.

Currently Active Assets on Macroaxis

When determining whether Dr Reddys Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Dr Reddys' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dr Reddys Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dr Reddys Laboratories Stock:
Check out Dr Reddys Piotroski F Score and Dr Reddys Altman Z Score analysis.
Note that the Dr Reddys Laboratories information on this page should be used as a complementary analysis to other Dr Reddys' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Complementary Tools for RDY Stock analysis

When running Dr Reddys' price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Money Managers
Screen money managers from public funds and ETFs managed around the world
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Bonds Directory
Find actively traded corporate debentures issued by US companies
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Is Dr Reddys' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dr Reddys. If investors know RDY will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dr Reddys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.103
Dividend Share
40
Earnings Share
3.75
Revenue Per Share
272.4618
Quarterly Revenue Growth
0.066
The market value of Dr Reddys Laboratories is measured differently than its book value, which is the value of RDY that is recorded on the company's balance sheet. Investors also form their own opinion of Dr Reddys' value that differs from its market value or its book value, called intrinsic value, which is Dr Reddys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dr Reddys' market value can be influenced by many factors that don't directly affect Dr Reddys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dr Reddys' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dr Reddys is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dr Reddys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.